Avenir Wellness Solutions, Inc., through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness. The company is headquartered in Sherman Oaks, California.
| Revenue (TTM) | $40.23M |
| Gross Profit (TTM) | $14.97M |
| EBITDA | $-12.21M |
| Operating Margin | 45.80% |
| Return on Equity | -3504.00% |
| Return on Assets | -8.89% |
| Revenue/Share (TTM) | $0.87 |
| Book Value | $0.00 |
| Price-to-Book | 767.77 |
| Price-to-Sales (TTM) | 5.50 |
| EV/Revenue | 4.369 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -7.70% |
| Shares Outstanding | $76.61M |
| Float | $32.66M |
| % Insiders | 52.34% |
| % Institutions | 1.19% |